Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-400
Closed -$20.3K – 155
2026
Q1
$20.3K Hold
400
– – 0.01% 146
2025
Q4
$11.8K Hold
400
– – 0.01% 141
2025
Q3
$10.3K Hold
400
– – 0.01% 142
2025
Q2
$11K Hold
400
– – 0.01% 145
2025
Q1
$11.3K Hold
400
– – 0.01% 144
2024
Q4
$16.6K Hold
400
– – 0.01% 143
2024
Q3
$26.7K Hold
400
– – 0.02% 124
2024
Q2
$47.5K Hold
400
– – 0.03% 121
2024
Q1
$42.6K Hold
400
– – 0.03% 120
2023
Q4
$39.8K Hold
400
– – 0.03% 118
2023
Q3
$39.8K Hold
400
– – 0.03% 118
2023
Q2
$48.6K Sell
400
-100
-20% -$13.3K 0.04% 130
2023
Q1
$76.8K Buy
+500
New +$82.5K 0.08% 125

Other funds holding MRNA

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s MRNA Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Moderna (MRNA) in Q2 2026, closing a stake of 400 shares — an estimated $20.3K sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in MRNA in Q1 2023 and held it in 13 quarters. The position peaked at $76.8K in Q1 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 400 Moderna shares in Q2 2026, an estimated $20.3K.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Moderna in Q1 2023 and held it in 13 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Moderna position peaked at $76.8K in Q1 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.